{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:50:01Z","timestamp":1772250601959,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijid.2024.107017","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T23:46:26Z","timestamp":1711064786000},"page":"107017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Vaccine-derived yellow fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with sofosbuvir"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3739-9601","authenticated-orcid":false,"given":"Tobias","family":"Weirauch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-5284","authenticated-orcid":false,"given":"Gerrit","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e1niel","family":"Cadar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Koepsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gundolf","family":"Sch\u00fcttfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"de Leuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.G.T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-9540","authenticated-orcid":false,"given":"Timo","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Wetzstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2024.107017_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107017_bib0002","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.2147\/DDDT.S99600","article-title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","volume":"10","author":"Thomas","year":"2016","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.ijid.2024.107017_bib0003","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.2147\/DDDT.S99600","article-title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","volume":"10","author":"Thomas","year":"2016","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.ijid.2024.107017_bib0004","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/bmt.2012.277","article-title":"Yellow fever vaccine viremia following ablative BM suppression in AML","volume":"48","author":"Avelino-Silva","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijid.2024.107017_bib0005","first-page":"5769","article-title":"Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)","author":"Seligman","year":"2014","journal-title":"Vaccine. Elsevier Ltd"},{"key":"10.1016\/j.ijid.2024.107017_bib0006","unstructured":"Staples JE. Yellow fever vaccine (2010). Available at: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5907a1.htm (accessed: 28 February 2024)."},{"issue":"9","key":"10.1016\/j.ijid.2024.107017_bib0007","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/21645515.2015.1022700","article-title":"Serious adverse events associated with yellow fever vaccine","volume":"11","author":"de Menezes Martins","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.ijid.2024.107017_bib0008","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3201\/eid1710.101789","article-title":"Yellow fever virus vaccine-associated deaths in young women","volume":"17","author":"Seligman","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2024.107017_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","volume":"13","author":"de Freitas","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2024.107017_bib0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.aohep.2019.09.001","article-title":"Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure","volume":"18","author":"Mendes","year":"2019","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.ijid.2024.107017_bib0011","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-021-05962-7","article-title":"Seroconversion of rheumatoid arthritis patients after yellow fever vaccination","volume":"41","author":"Dos Reis","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijid.2024.107017_bib0012","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.38960","article-title":"Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever","volume":"67","author":"Oliveira","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.ijid.2024.107017_bib0013","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T cells complement antibodies in protecting against yellow fever virus","volume":"194","author":"Bassi","year":"2015","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2024.107017_bib0014","doi-asserted-by":"crossref","first-page":"taac095","DOI":"10.1093\/jtm\/taac095","article-title":"Yellow fever vaccine safety in immunocompromised individuals: a systematic review and meta-analysis","volume":"30","author":"Wigg de Ara\u00fajo Lagos","year":"2023","journal-title":"J Travel Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:01:15Z","timestamp":1715756475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":14,"alternative-id":["S1201971224000882"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107017","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-derived yellow fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with sofosbuvir","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107017"}}